Global Point-of-care Infectious Disease Diagnostics Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 HIV POC
  • 1.4.3 Clostridium Difficile POC
  • 1.4.4 HBV POC
  • 1.4.5 Respiratory Syncytial Virus POC
  • 1.4.6 HPV POC
  • 1.4.7 Influenza/Flu POC
  • 1.4.8 HCV POC
  • 1.4.9 MRSA POC
  • 1.4.10 TB and Drug-Resistant TB POC
• 1.5 Market by Application
  • 1.5.1 Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Home
  • 1.5.5 Assisted Living Healthcare Facilities
  • 1.5.6 Laboratories
  • 1.5.7 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2015-2026)
• 2.2 Global Point-of-care Infectious Disease Diagnostics Growth Trends by Regions
  • 2.2.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Point-of-care Infectious Disease Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Point-of-care Infectious Disease Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Market Size
  • 3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio
  • 3.2.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2019
• 3.3 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
• 3.5 Date of Enter into Point-of-care Infectious Disease Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
• 6.2 Point-of-care Infectious Disease Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
• 7.2 Point-of-care Infectious Disease Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
• 8.2 Point-of-care Infectious Disease Diagnostics Key Players in China (2019-2020)
• 8.3 China Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 8.4 China Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
• 9.2 Point-of-care Infectious Disease Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
• 10.2 Point-of-care Infectious Disease Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
• 11.2 Point-of-care Infectious Disease Diagnostics Key Players in India (2019-2020)
• 11.3 India Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 11.4 India Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
• 12.2 Point-of-care Infectious Disease Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Thermo Fisher Scientific
  • 13.1.1 Thermo Fisher Scientific Company Details
  • 13.1.2 Thermo Fisher Scientific Business Overview
  • 13.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction
  • 13.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020))
  • 13.1.5 Thermo Fisher Scientific Recent Development
• 13.2 Abbott
  • 13.2.1 Abbott Company Details
  • 13.2.2 Abbott Business Overview
  • 13.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction
  • 13.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.2.5 Abbott Recent Development
• 13.3 Calypte Biomedical
  • 13.3.1 Calypte Biomedical Company Details
  • 13.3.2 Calypte Biomedical Business Overview
  • 13.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction
  • 13.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.3.5 Calypte Biomedical Recent Development
• 13.4 Chembio Diagnostic Systems
  • 13.4.1 Chembio Diagnostic Systems Company Details
  • 13.4.2 Chembio Diagnostic Systems Business Overview
  • 13.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction
  • 13.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.4.5 Chembio Diagnostic Systems Recent Development
• 13.5 Meridian Bioscience
  • 13.5.1 Meridian Bioscience Company Details
  • 13.5.2 Meridian Bioscience Business Overview
  • 13.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction
  • 13.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.5.5 Meridian Bioscience Recent Development
• 13.6 MedMira
  • 13.6.1 MedMira Company Details
  • 13.6.2 MedMira Business Overview
  • 13.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction
  • 13.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.6.5 MedMira Recent Development
• 13.7 Trinity Biotech
  • 13.7.1 Trinity Biotech Company Details
  • 13.7.2 Trinity Biotech Business Overview
  • 13.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction
  • 13.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.7.5 Trinity Biotech Recent Development
• 13.8 Sekisui Diagnostics
  • 13.8.1 Sekisui Diagnostics Company Details
  • 13.8.2 Sekisui Diagnostics Business Overview
  • 13.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction
  • 13.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.8.5 Sekisui Diagnostics Recent Development
• 13.9 OraSure Technologies
  • 13.9.1 OraSure Technologies Company Details
  • 13.9.2 OraSure Technologies Business Overview
  • 13.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction
  • 13.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.9.5 OraSure Technologies Recent Development
• 13.10 Quidel
  • 13.10.1 Quidel Company Details
  • 13.10.2 Quidel Business Overview
  • 13.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction
  • 13.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
  • 13.10.5 Quidel Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer